C Ray Therapeutics - Crunchbase Company Profile & Funding

Q: Where is C Ray Therapeutics's headquarters?

C Ray Therapeutics is located in Chengdu, Sichuan, China.

Q: Who invested in C Ray Therapeutics?

C Ray Therapeutics has 6 investors including Shenzhen Capital Group And Guanghua Wutong Fund.

Q: How much funding has C Ray Therapeutics raised to date?

C Ray Therapeutics has raised obfuscated.

Overview

C Ray Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About C Ray Therapeutics

CB Rank

19305

C Ray Therapeutics develops healthcare advancements through nuclear medicine.

Founded

obfuscation

Private

Series A

Chengdu, Sichuan, China

51-100

www.c-raytherapeutics.com

Health Care

Health Diagnostics

Medical

Nuclear

Funding Rounds

Series A

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Details

Legal Name

C Ray Therapeutics (Chengdu) Co., Ltd

Also Known As

Tongrui Biotech, 通瑞生物, Tongrui Biotechnology, Tongrui Biopharmaceuticals

Operating Status

Active

Company Type

For Profit

About the Company

C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020.

Phone Number

+86 028-60912198-8088

Contact Email

BD@c-raytherapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

C Ray Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

CRDMO Services for Radiopharmaceuticals

End-to-end contract research, development, and manufacturing services for radiopharmaceuticals from discovery to commercial supply.

Pre-clinical Evaluation Services

Pharmacological, toxicological, and efficacy evaluation of radiopharmaceuticals using in vitro and in vivo models to support IND and NDA submissions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A
obfuscated obfuscation	Series A - C Ray Therapeutics	5	obfuscated obfuscation	Shenzhen Capital Group, Tailong Investment	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Shenzhen Capital Group	Yes	Series A - C Ray Therapeutics	—
Shenzhen Capital Group	Yes	Series A - C Ray Therapeutics	—
Shenzhen Capital Group	Yes	Series A - C Ray Therapeutics	—
Shenzhen Capital Group	Yes	Series A - C Ray Therapeutics	—
Shenzhen Capital Group	Yes	Series A - C Ray Therapeutics	—